Gender associated effects of the ethanolic extracts of Chinese propolis on the hepatic transcriptome in ethanol-treated mice

Document Type : Original Article


1 College of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, Jiangsu Province, China

2 Fubiao Biotech Co, Ltd, Huai-an 211799, Jiangsu Province, China

3 Fubiao Biotech Co., Ltd., Huai-an 21799, Jiangsu Province, China

4 Joint International Research Laboratory of Agricultural & Agri-Product Safety, Yangzhou University, Yangzhou 225009, Jiangsu Province, China

5 College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, Jiangsu Province, China


Objective(s): The current study investigated the potential hepatoprotective effects of the ethanolic extracts of Chinese propolis (EECP) on ethanol-induced fatty liver in mice.
Materials and Methods: C57BL/6J mice were orally gavaged with 50% ethanol alone or co-administrated with EECP at the dose of 0.2 ml/kg bodyweight for eight weeks. The dose for ethanol was 6 ml/kg bodyweight for the first two experimental weeks, and then increased to 8, 10, and 12 ml/kg bodyweight every two experimental weeks. Alterations in the hepatic transcriptome due to concomitant administration of EECP were investigated using RNA-Seq technique.
Results: Our results showed that the main EECP-responsive genes were involved in lipid syntheses, which were significantly down-regulated in both female and male mice co-administrated with EECP. In female mice, these differentially expressed genes (DEGs) were mainly associated with fatty acid biosynthesis. While in male mice, these DEGs were mainly involved in the steroid metabolic process and cholesterol biosynthetic process. Despite the sex-associated responses in lipid metabolism, EECP also exerted other beneficial effects in female mice through modulation of the cytokine-cytokine receptor interaction pathway that helped explaining its hepato-protective effectiveness.
Conclusion: Our findings indicated that the mechanism regarding the hepato-protective effects of EECP was gender-dependent, which is worthy of further investigation during the development of therapeutic interventions using EECP to reduce the adverse influences of ethanol.


Main Subjects

1. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol 2013; 59: 160-168.
2. Poynard T, Thabut D, Chryssostalis A, Taieb J, Ratziu V. Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible? J Hepatol 2003; 38: 518-520.
3. Hmoud BS, Patel K, Bataller R. Singal AK. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Liver Int 2016; 36: 721-728.
4. Wagh VD. Propolis: a wonder bees product and its pharmacological potentials. Adv Pharmacol Sci 2013; 2013: 308249.
5. Gardana C, Scaglianti M, Pietta P, Simonetti P. Analysis of the polyphenolic fraction of propolis from different sources by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2007; 45: 390-399.
6. Balta C, Herman H, Boldura OM, Gasca I, Rosu M, Ardelean A, et al. Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-beta/Smad signaling pathway. Chem Biol Interact 2015; 240: 94-101.
7. Hermenean A, Mariasiu T, Navarro-Gonzalez I, Vegara-Meseguer J, Miutescu E, Chakraborty S, et al. Hepatoprotective activity of chrysin is mediated through TNF-alpha in chemically-induced acute liver damage: An In vivo study and molecular modeling. Exp Ther Med 2017; 13:1671-1680.
8. Ali N, Rashid S, Nafees S, Hasan SK, Sultana S. Beneficial effects of chrysin against methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. Mol Cell Biochem 2014; 385: 215-223.
9. Ciftci O, Vardi N, Ozdemir I. Effects of quercetin and chrysin on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced hepatotoxicity in rats. Environ Toxicol 2013; 28:146-154.
10. Rehman MU, Ali N, Rashid S, Jain T, Nafees S, Tahir M, et al. Alleviation of hepatic injury by chrysin in cisplatin administered rats: probable role of oxidative and inflammatory markers. Pharmacol Rep 2014; 66: 1050-1059.
11. Zhou F, Wang A, Li D, Wang Y, Lin L. Pinocembrin from Penthorum chinense Pursh suppresses hepatic stellate cells activation through a unified SIRT3-TGF-beta-Smad signaling pathway. Toxicol Appl Pharmacol 2018; 341: 38-50.
12. Sun C, Wu Z, Wang Z, Zhang H. Effect of ethanol/water solvents on phenolic profiles and antioxidant properties of Beijing propolis extracts. Evid Based Complement Alternat Med 2015; 2015: 595393.
13. Luo Q, Zhu L, Ding J, Zhuang X, Xu L, Chen F. Protective effect of galangin in Concanavalin A-induced hepatitis in mice. Drug Des Devel Ther 2015; 9: 2983-2992.  
14. Tsai MS, Chien CC, Lin TH, Liu CC, Liu RH, Su HL, et al. Galangin prevents acute hepatorenal toxicity in novel propacetamol-induced acetaminophen-overdosed mice. J Med Food 2015; 18: 1187-1197.
15. Wang X, Gong G, Yang W, Li Y, Jiang M, Li L. Antifibrotic activity of galangin, a novel function evaluated in animal liver fibrosis model. Environ Toxicol Pharmacol 2013; 36: 288-295.
16. Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009; 33: 191-205.
17. Ghosh Dastidar S, Warner JB, Warner DR, McClain CJ, Kirpich IA. Rodent models of alcoholic liver disease: role of binge ethanol administration. Biomole 2018; 8: 3.
18. Bai YF, Li XJ, Li YG, Wang LF, Wan RL, Li B, et al. Analysis of alcoholic fatty liver model establishment in inbred mice. Chin J Comp Med 2014; 24: 8-11.
19. Ye MH, Xu MT, Chen CJ, He Y, Ding MM, Nie JY, et al. Expression analyses of candidate genes related to meat quality traits in squabs from two breeds of meat-type pigeon. J Anim Physiol An N 2018;102: 727-735.
20. Akhavanpoor M, Gleissner CA, Gorbatsch S, Doesch AO, Akhavanpoor H, Wangler S, et al. CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions. Drug Des Devel Ther 2014; 8: 2359-2371.
21. Offiah I, Didangelos A, Dawes J, Cartwright R, Khullar V, Bradbury EJ, et al. The expression of inflammatory mediators in bladder pain syndrome. Eur Urol 2016; 70: 283-290.
22. Barrett R, Zhang X, Koon HW, Vu M, Chang JY, Yeager N, et al. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis. Am J Pathol 2012; 180: 636-649.
23. Singh RK, Perks WV, Twohig JP, Kidd EJ, Broadley K, Farrow SN, et al. Death receptor 3 regulates distinct pathological attributes of acute versus chronic murine allergic lung inflammation. Cell Immunol 2017; 320: 62-70.
24. Takedatsu H, Michelsen KS, Wei B, Landers CJ, Thomas LS, Dhall D, et al. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 2008; 135:552-567.
25. Aguilar-Valenzuela R, Carlsen ED, Liang Y, Soong L, Sun, J. Hepatocyte growth factor in dampening liver immune-mediated pathology in acute viral hepatitis without compromising antiviral activity. J Gastroenterol Hepatol 2014; 29: 878-886.
26. Giannopoulou M, Dai C, Tan X, Wen X, Michalopoulos GK, Liu, Y. Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling. Am J Pathol 2008; 173: 30-41.
27. Lebeis SL, Powell KR, Merlin D, Sherman M.A, Kalman D. Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun 2009; 77: 604-614.
28. Tian T, Jin MQ, Dubin K. IL-1R type 1-deficient mice demonstrate an impaired host immune response against cutaneous vaccinia virus infection. J Microbiol 2017; 198: 4341-4351.
29. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011; 1813: 878-888.
30. Vergara C, Ramirez B. CNTF, a pleiotropic cytokine: emphasis on its myotrophic role. Brain Res Brain Res Rev 2004; 47:161-173.
31. Elson GC, Lelievre E, Guillet C, Chevalier S, Plun-Favreau H, Froger J, et al. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci 2000; 3:867-872.
32. Stefanovic L, Stefanovic B. Role of cytokine receptor-like factor 1 in hepatic stellate cells and fibrosis. World J Hepatol 2012; 4: 356-364.
33. Chang B, Punj V, Shindo M, Chaudhary PM. Adenoviral-mediated gene transfer of ectodysplasin-A2 results in induction of apoptosis and cell-cycle arrest in osteosarcoma cell lines. Cancer Gene Ther 2007; 14: 927-933.
34. Sisto M, Lorusso L, Lisi S. X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjogren’s syndrome. Clin Exp Med 2017; 17: 111-119.
35. Tanikawa C, Ri C, Kumar V, Nakamura Y, Matsuda K. Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway. Mol Cancer Res 2010; 8: 855-863.
36. Durazzo M, Belci P, Collo A, Prandi V, Pistone E, Martorana M, et al. Gender specific medicine in liver diseases: a point of view. World J Gastroenterol 2014; 20: 2127-2135.
37. Müller C. Liver, alcohol and gender. Wiener Medizinische Wochenschrift 2006; 156: 523-526.
38. Kasztelan-Szczerbinska B, Surdacka A, Celinski K, Rolinski J, Zwolak A, Miacz S. et al. Prognostic significance of the systemic inflammatory and immune balance in alcoholic liver disease with a focus on gender-related differences. PLoS One 2015; 10: e0128347.
39. Cangemi R, Romiti GF, Campolongo G, Ruscio E, Sciomer S, Gianfrilli D. et al. Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate. Pharmacol Res 2017;117:148-155.
40. Margalef M, Pons Z, Iglesias-Carres L, Arola L, Muguerza B, Arola-Arnal A. Gender-related similarities and differences in the body distribution of grape seed flavanols in rats. Mol Nutr Food Res 2016; 60: 760-772.
41. Campesi I, Marino M, Cipolletti M, Romani A, Franconi F. Put “gender glasses” on the effects of phenolic compounds on cardiovascular function and diseases. Eur J Nutr 2018; 57: 2677-2691.